JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 September 2006

J Clin Pathol. Published Online First: 7 March 2006. doi:10.1136/jcp.2005.031732
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
jcp.2005.031732v1
59/9/916    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ostalska-Nowicka, D.
Right arrow Articles by Witt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ostalska-Nowicka, D.
Right arrow Articles by Witt, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Histopathology

Ezrin: a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach

Danuta Ostalska-Nowicka 1*, Jacek Zachwieja 1, Michal Nowicki 2, Elzbieta Kaczmarek 3, Aldona Siwinska 4 and Martin Witt 5

1 Department of Pediatric Cardiology and Nephrology, University of Medical Sciences in Poznan, Poland
2 Department of Histology and Embryology, University of Medical Sciences in Poznan, Poland
3 Department of Clinical Pathomorphology, University of Medical Sciences in Poznan, Poland
4 Department of Pediatric Cardiology and Nephrology, Univeristy of Medical Sciences in Poznan
5 Department of Anatomy, Technical University in Dresden, Germany

* To whom correspondence should be addressed. E-mail: dostalska{at}interia.pl.

Accepted 3 October 2005


*   Abstract

Introduction: Minimal change disease (MCD) and diffuse mesangial proliferation (DMP) are the most common pathomorphological forms of nephrotic syndrome glomerulopathies in children. The clinical course of DMP can be characterized by sensitivity (DMP-S) or resistance (DMP-R) to steroids (the unfavourable course of the glomerulopathy). Although the clinical process of DMP-S and DMP-R are intially identical, the resistance to steroids may be foreseen by the immunohistochemical expression of cytoskeleton - associated proteins.

Aim: To estimate the immunohistochemical expression of ezrin in children with MCD, DMP and focal segmental glomerulosclerosis (FSGS) and to evaluate its usefullness in prognosis of the resistance to steroids.

Methods: Material included renal biopsies of MCD (n = 15), DMP (n = 16) and FSGS (n = 6). The control tissue consisted of normal appearing cortex taken from kidneys resected for localized neoplasms (n=6). The indirect immunohistochemical protocol with the use of a monoclonal antibody directed against ezrin was employed.

Results: Immunohistochemical expression of ezrin decreased from MCD, DMP-S, DMP-R to FSGS cases. Except of DMP-R and FSGS (p>0.05) the difference in the ezrin expression within podocytes was statistically significant.

Conclusions: Ezrin can be a potent marker of podocyte injury (podocytopathy) and may help in the histological qualification of MCD, DMP and FSGS. The increased permeability of the filtration barrier in steroid-resistant and proteinuric glomerulopathies may be a consequence of subcellular alterations of podocyte-associated proteins following decreased expression of ezrin.

Key Words: ezrin, immunohistochemistry, nephrotic syndrome, podocyte




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
K. N. Lai, J. C. K. Leung, L. Y. Y. Chan, M. A. Saleem, P. W. Mathieson, K. Y. Tam, J. Xiao, F. M. Lai, and S. C. W. Tang
Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy
Nephrol. Dial. Transplant., August 6, 2008; (2008) gfn441v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.